Last updated: 2026-10-11 02:04:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
electroCore, Inc. (ECOR) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9,62, with a market capitalization of $85,74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,41 to $12,70. This page covers its latest market performance, valuation, price trends and company information.
$85,74M | |
$9,37 | |
$303,45 | |
$2,92 | |
$9,51 | |
42,26K | |
81,53K | |
-- | |
$12,70 | |
$4,41 | |
-- | |
-- |
electroCore, Inc. (ECOR) last closed at $9,51 as of 2026-10-09 19:59:03, unchanged from the previous close of $9,51.
During the latest regular trading session, ECOR traded between $2,92 and $303,45, with a volume of 42,26K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, electroCore, Inc. (ECOR) moved from $10,32 to $9,62, representing a decline of 6,74% ($0,70).
The stock traded between $9,25 and $11,08 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 62,51 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 62,8%
ECOR is currently trading at $9,62, placing it 62,8% of the way from its 52-week low of $4,41 to its 52-week high of $12,70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 83 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of electroCore, Inc. (ECOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.